Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

SELL
$1.79 - $2.9 $93,037 - $150,730
-51,976 Reduced 62.2%
31,586 $77,000
Q1 2023

May 03, 2023

BUY
$2.65 - $3.81 $42,771 - $61,493
16,140 Added 23.94%
83,562 $248,000
Q4 2022

Feb 13, 2023

BUY
$3.38 - $4.22 $156,818 - $195,791
46,396 Added 220.66%
67,422 $246,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $5.83 $1,608 - $2,734
469 Added 2.28%
21,026 $76,000
Q2 2022

Aug 08, 2022

BUY
$4.41 - $5.69 $90,656 - $116,969
20,557 New
20,557 $109,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $375M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Integrated Wealth Concepts LLC Portfolio

Follow Integrated Wealth Concepts LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Wealth Concepts LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Wealth Concepts LLC with notifications on news.